TrialInternational clinical psychopharmacology2020

Intravenous vortioxetine to accelerate onset of effect in major depressive disorder: a 7-day randomized, double-blind, placebo-controlled exploratory study.

Elmars Rancans et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.